Biogen Idec

Biogen Idec Photos

Exterior RTP
Bird's Eye View
Interior RTP

+ Add Photo

Biogen Idec Reviews

244 Reviews
244 Reviews
Rating Trends

Recommend to a friend
Approve of CEO
Biogen Idec CEO and Director George A. Scangos
George A. Scangos
142 Ratings

    VP R&D

    • Comp & Benefits
    • Work/Life Balance
    • Senior Management
    • Culture & Values
    • Career Opportunities
    Current Employee - Anonymous Employee
    Current Employee - Anonymous Employee

    I have been working at Biogen Idec full-time (more than 5 years)


    Great products and interesting pipeline


    Management is unstable with frequent reorganizations for no real apparent reason.

    Advice to ManagementAdvice

    Pay more attention to professional development / career management

    Neutral Outlook

Biogen Idec Interviews

Updated Jan 16, 2015
Updated Jan 16, 2015

Interview Experience

Interview Experience


Getting an Interview

Getting an Interview


Interview Difficulty


Interview Difficulty




    Associate Director Interview

    Anonymous Employee
    Anonymous Employee
    Application Details

    I applied online – interviewed at Biogen Idec.

    Interview Details

    Applied online and received a response within 4 days. Was contacted by a talent acquisition manager to schedule time for a phone interview a few days later. The phone interview was about 30 minutes, half of the time spent answering their questions and half of the time asking questions. The questions were pretty typical of a phone screening (start off by telling me about yourself, why this position, why Biogen Idec).

    Interview Questions
    • What do you think will be your biggest challenge in the position?   Answer Question
    No Offer
    Positive Experience
    Average Interview

Biogen Idec Awards & Accolades

Something missing? Add an award
Top Employer, Science Magazine, 2012
Top Employer, Science Magazine, 2011
Show More

Additional Info

Unlock Profile
Headquarters Cambridge, MA
Size 5000+ Employees
Founded 1978
Type Company - Public (BIIB)
Industry Biotech & Pharmaceuticals
Revenue $5 to $10 billion (USD) per year
Competitors Unknown

With its pipeline full of biotech drugs, Biogen Idec aims to meet the unmet needs of patients around the world. The biotech giant is focused on developing treatments in the areas of immunology and neurology. Its product roster includes best-selling Avonex, a popular drug for the treatment of relapsing multiple sclerosis (MS); Tysabri, a drug treatment for MS and Crohn's disease (developed with Elan); Rituxan, a monoclonal antibody developed jointly with Genentech that treats non-Hodgkin's lymphoma and rheumatoid arthritis; and Fumaderm, a psoriasis drug marketed in... More

Work at Biogen Idec? Share Your Experiences

Biogen Idec

Click to Rate